Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS- the Fabry Outcome Survey | Charles Explorer

Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS- the Fabry Outcome Survey

Publication

Abstract

Fabry disease

People